0001840292 false 0001840292 2022-08-23 2022-08-23 0001840292 HLGN:CommonStock0.0001ParValuePerShareMember 2022-08-23 2022-08-23 0001840292 HLGN:WarrantsEachWholeWarrantExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2022-08-23 2022-08-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares





Washington, D.C. 20549





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): August 23, 2022


Heliogen, Inc.

(Exact name of registrant as specified in its charter)


Delaware   001-40209   85-4204953

(State or other jurisdiction of


  (Commission File Number)  

(I.R.S. Employer

Identification No.) 


130 West Union Street
Pasadena, California 91103
(Address of Principal Executive Offices)
Registrant’s telephone number including area code:  (626) 720-4530


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.0001 par value per share   HLGN   New York Stock Exchange
Warrants, each whole warrant exercisable for shares of Common stock at an exercise price of $11.50 per share   HLGN.W   New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 7.01 Regulation FD Disclosure.


On August 3, 2022, David Crane, a member of the Board of Directors (the “Board”) of Heliogen, Inc. (the “Company”), was nominated to serve as the Under Secretary for Infrastructure at the U.S. Department of Energy. As previously announced on August 15, 2022, Mr. Crane informed the Board that to avoid any potential conflict with the Company, he would be resigning from the Board and the committees he served on, effective on September 5, 2022.  The Company is excited for David to take on this role continuing his commitment to renewable energy that he has exhibited over his career, and thanks him for his service.


Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.


104   Cover Page Interactive Data File (embedded within the Inline XBRL document).







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


  Heliogen, Inc.
  /s/ Christiana Obiaya
  Christiana Obiaya
Dated: August 23, 2022 Chief Financial Officer